Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
6.06
+0.52 (9.39%)
At close: Jul 14, 2026, 4:00 PM EDT
6.09
+0.03 (0.50%)
After-hours: Jul 14, 2026, 6:40 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $7.07 million as of July 14, 2026. Its market cap has decreased by -48.10% in one year.
Market Cap
7.07M
Enterprise Value
-1.72M
1-Year Change
-48.10%
Ranking
Category
Stock Price
$6.06
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $7.07M, a decrease of -96.42%. That is a compound annual growth rate of -46.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 7.07M | -24.96% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 7.73M |
| PharmaCyte Biotech | 7.40M |
| Kairos Pharma | 7.28M |
| CNS Pharmaceuticals | 7.10M |
| Acurx Pharmaceuticals | 7.09M |
| Can-Fite BioPharma | 7.07M |
| Cadrenal Therapeutics | 6.94M |
| Xenetic Biosciences | 6.87M |